ACI’S HATCH-WAXMAN SERIES ADVISORY BOARD
American Conference Institute’s Hatch-Waxman Series Advisory board was created as a part of ACI’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of all-in-house advisers, including Chief IP and very senior IP/Patent counsel from the leading brand name and generic pharmaceutical companies in the country and in some cases the world. This ‘inner circle’ counsels ACI on the impact of litigation trends and emerging topics.
Ryan M. Daniel
VP, Associate General Counsel, Corporate and Business Transactions
Biopharmaceuticals
Fresenius Kabi, LLC
Stephanie Donahue
Principal Counsel – Global Patent
Litigation, Global IP Department
Legal, Ethics & Business Integrity
Sanofi-Aventis
Serena Farquharson-Torres
Executive Director, Assistant General Counsel
Innovation Law
Bristol Myers Squibb
Linda Friedlieb
Division Counsel
AbbVie
Andrea Hutchison
Senior Associate General Counsel, IP Litigation
Gilead Sciences
Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals
James Kellerman
Senior Vice President, Intellectual Property
Astellas Pharma US, Inc.
Neema Kumar
Vice President, IP, North America
Sandoz
James P. Leeds
Assistant General Patent Counsel
Eli Lilly & Company
Josephine Liu, Ph.D., J.D.
Vice President of IP, North America (ad interim)
Sandoz
Mary Morry
Counsel
Merck & Company
Jeffrey N. Myers, Ph.D.
Vice President & Assistant General Counsel
Pfizer Inc
Aaron Pereira
Senior Director of Patents
Ferring Pharmaceuticals
Pearl T. L. Siew
Senior Vice President and Head of IP
Design Therapeutics
Brian Stone
Vice President
Assistant Global General Counsel Regulatory
Mylan
Lars P. Taavola
VP, Chief IP Counsel & General
Counsel, Specialty Generics
Mallinckrodt Pharmaceuticals
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Policy
Amneal Pharmaceuticals
Peter Waibel
Head, US Patent Litigation
Novartis Pharmaceuticals Corporation
Kevin Zive
Vice President, General Counsel, and Head of Global Intellectual Property
Apotex Inc.
Emeritus Members
Stephen R. Auten
Partner, Chair of Pharmaceutical & Life Sciences Litigation
Taft Stettinius & Hollister LLP
(Former Vice President, IP, Sandoz, Inc.)
Guy Donatiello
Senior Vice President, Intellectual Property
Endo Pharmaceuticals
George W. Johnston
Counsel
Gibbons P.C.
(Former Vice President & Chief Patent Counsel, Hoffmann-La Roche)
David H. Silverstein, M.S., J.D.
Partner
Axinn, Veltrop & Harkrider LLP
(Former Senior Director, Intellectual Property, Par Pharmaceutical, Inc)
Meg Snowden
Shareholder
Margaret M. Snowden, P.C.
(Former Vice President,, Intellectual Property, Impax Laboratories)
Warning: Attempt to read property "ID" on null in /srv/users/americanconference/apps/americanconference/public/wp-content/themes/c5group/lib/Reshift/PostType/PostAbstract.php on line 566